Advertisement

Exercise training attenuates insulin resistance and improves β-cell function in patients with systemic autoimmune myopathies: a pilot study

  • Diego Sales de OliveiraEmail author
  • Isabela Bruna Pires Borges
  • Jean Marcos de Souza
  • Bruno Gualano
  • Rosa Maria Rodrigues Pereira
  • Samuel Katsuyuki Shinjo
Original Article

Abstract

Introduction/objectives

To assess the effects of exercise training on insulin resistance and β-cell function in patients with systemic autoimmune myopathies (SAMs).

Method

This quasi-experimental, prospective study includes 9 patients with SAMs (six with dermatomyositis, two with antisynthetase syndrome, and one with polymyositis). Patients were submitted to a 12-week, twice a week, exercise training program comprising aerobic and resistance exercises. Baseline and after the intervention, we evaluated disease status, aerobic capacity, muscle strength, body composition, insulin resistance, and β-cell function parameters.

Results

The patients have a mean age of 46.7 years and stable disease. No clinical or laboratory parameter impairment was observed after the intervention. Compared with baseline, aerobic capacity, muscle strength, and function increased after 12 weeks (P < 0.05), while no changes were observed for body composition. Data from the oral glucose tolerance test showed that exercise did not change glucose area under the curve (AUC), whereas insulin and C-peptide AUC decreased significantly (P < 0.05). Furthermore, Matsuda index and HOMA2 percentage (both surrogates of insulin resistance) also improved (P < 0.05).

Conclusion

Exercise training improved aerobic capacity, muscle strength, and muscle function in patients with SAMs. In addition, exercise training led to an attenuation of insulin resistance and improvements in β-cell function parameters. These data indicate that exercise training can mitigate metabolic impairments, attenuating the cardiovascular risk in SAMs.

Key Points

Exercise training improved aerobic capacity, muscle strength, and function without disease impairment

• Exercise training was capable of improve insulin resistance and β-cell function in patients with SAM

• These results suggest that exercise can mitigate metabolic impairments in patients with SAM, attenuating the cardiovascular risk

Keywords

Exercise training Insulin resistance Myositis Physical exercise β-Cell function 

Notes

Acknowledgments

The authors are thankful to Rafael Giovane Misse and Alexandre Moura dos Santos for exercise training assistance, Laboratorio de Avaliação e Condionamento em Reumatologia (LACRE) for the exercise room availability, and Lilian Takayama for densitometry analysis.

Financial support

Funding was provided by the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) to D.S.O. (no. 2016/19771-5), to I.B.P.B. (no. 2016/20371-1), and to S.K.S. (no. 2017/13109-1) and Faculdade de Medicina da Universidade de Sao Paulo to S.K.S.

Compliance with ethical standards

Disclosures

None.

References

  1. 1.
    Selva-O’Callaghan A, Pinal-Fernandez I, Trallero-Araguás E, Milisenda JC, Grau-Junyent JM, Mammen AL (2018) Classification and management of adult inflammatory myopathies. Lancet Neurol 17:816–828CrossRefGoogle Scholar
  2. 2.
    Dalakas MC (2010) Inflammatory muscle diseases: a critical review on pathogenesis and therapies. Curr Opin Pharmacol 10:346–352CrossRefGoogle Scholar
  3. 3.
    De Moraes MT, de Souza FH, de Barros TB, Shinjo SK (2016) Analysis of metabolic syndrome in adult dermatomyositis with a focus on cardiovascular disease. Arthritis Care Res 2013;65:793–799Google Scholar
  4. 4.
    Silva MG, Borba EF, Mello SB, Shinjo SK Serum adipocytokine profile and metabolic syndrome in young adult female dermatomyositis patients. Clinics (São Paulo) 71:709–714Google Scholar
  5. 5.
    Araujo PAO, Silva MG, Borba EF, Shinjo SK (2018) High prevalence of metabolic syndrome in antisynthetase syndrome. Clin Exp Rheumatol 36:241–247Google Scholar
  6. 6.
    De Souza FH, Shinjo SK (2014) The high prevalence of metabolic syndrome in polymyositis. Clin Exp Rheumatol 32:82–87Google Scholar
  7. 7.
    Roberts CK, Hevener AL, Barnard RJ (2013) Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compr Physiol 3:1–58Google Scholar
  8. 8.
    Oliveira DS, Guimarães MS, Shinjo SK (2018) Insulin resistance is increased in adult patients with dermatomyositis. MedicalExpress 5Google Scholar
  9. 9.
    Alemo Munters L, Dastmalchi M, Andgren V, Emilson C, Bergegard J, Regardt M et al (2013) Improvement in health and possible reduction in disease activity using endurance exercise in patients with established polymyositis and dermatomyositis: a multicenter randomized controlled trial with a 1-year open extension follow up. Arthritis Care Res 65:1959–1968CrossRefGoogle Scholar
  10. 10.
    Munters LA, Loell I, Ossipova E, Raouf J, Dastmalchi M, Lindroos E, Chen YW, Esbjörnsson M, Korotkova M, Alexanderson H, Nagaraju K, Crofford LJ, Jakobsson PJ, Lundberg IE (2016) Endurance exercise improves molecular pathways of aerobic metabolism in patients with myositis. Arthritis Rheum 68:1738–1750CrossRefGoogle Scholar
  11. 11.
    De Souza JM, de Oliveira DS, Perin LA, Misse RG, Dos Santos AM, Gualano B et al (2019) Feasibility, safety and efficacy of exercise training in immune-mediated necrotising myopathies: a quasi-experimental prospective study. Clin Exp Rheumatol 37:235–241Google Scholar
  12. 12.
    Motahari-Tabari N, Ahmad Shirvani M, Shirzad-E-Ahoodashty M, Yousefi-Abdolmaleki E, Teimourzadeh M (2014) The effect of 8 weeks aerobic exercise on insulin resistance in type 2 diabetes: a randomized clinical trial. Global J Health Sci 7:115–121CrossRefGoogle Scholar
  13. 13.
    Benatti FB, Miyake CNH, Dantas WS, Zambelli VO, Shinjo SK, Pereira RMR, Silva MER, Sá-Pinto AL, Borba E, Bonfá E, Gualano B (2018) Exercise increases insulin sensitivity and skeletal muscle AMPK expression in systemic lupus erythematosus: a randomized controlled trial. Front Immunol 9:906CrossRefGoogle Scholar
  14. 14.
    Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, de Visser M (2017) International Myositis Classification Criteria Project Consortium, the Euromyositis Register, and the Juvenile Dermatomyositis Cohort Biomarker Study and Repository (UK and Ireland). 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheum 69:2271–2282CrossRefGoogle Scholar
  15. 15.
    Connors GR, Christopher-Stine L, Oddis CV, Danoff SK (2010) Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest 138:1464–1474CrossRefGoogle Scholar
  16. 16.
    Wasserman K, Whipp BJ, Koyl SN, Beaver WL (1973) Anaerobic threshold and respiratory gas exchange during exercise. J Appl Physiol 35:236–243CrossRefGoogle Scholar
  17. 17.
    Brown LE, Weir JP (2001) ASEP procedures recommendation I: accurate assessment of muscular strength and power. J Exerc Physiol 4:1–21Google Scholar
  18. 18.
    Bohannon RW (20098) Hand-grip dynamometry predicts future outcomes in aging adults. J Geriatr Phys Ther 31:3–10Google Scholar
  19. 19.
    Podsiadlo D, Richardson S (1991) The timed “up & go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39:142–148CrossRefGoogle Scholar
  20. 20.
    Jones CJ, Rikli RE, Beam WC (1999) A 30-s chair-stand test as a measure of lower body strength in community-residing older adults. Res Q Exerc Sport 70:113–119CrossRefGoogle Scholar
  21. 21.
    Bartoli E, Fra GP, Carnevale Schianca GP (2011) The oral glucose tolerance test (OGTT) revisited. Eur J Intern Med 22:8–12CrossRefGoogle Scholar
  22. 22.
    Qiao Q, Pyörälä K, Pyörälä M, Nissinen A, Lindström J, Tilvis R et al (2002) Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J 23:1267–1275CrossRefGoogle Scholar
  23. 23.
    Muniyappa R, Lee S, Chen H, Quon MJ (2008) Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 294:15–26CrossRefGoogle Scholar
  24. 24.
    Borai A, Livingstone C, Kaddam I, Ferns G (2011) Selection of the appropriate method for the assessment of insulin resistance. BMC Med Res Methodol 11:158CrossRefGoogle Scholar
  25. 25.
    Gutch M, Kumar S, Razi SM, Gupta KK, Gupta A (2015) Assessment of insulin sensitivity/resistance. Indian J Endocrinol Metab 19:160–164CrossRefGoogle Scholar
  26. 26.
    Isenberg DA, Allen E, Farewell V, Ehrenstein MR, Hanna MG, Lundberg IE et al International Myositis and Clinical Studies Group (IMACS) (2004) International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford) 43:49–54Google Scholar
  27. 27.
    Sánchez-Pérez H, Tejera-Segura B, de Vera-González A, González-Delgado A, Olmos JM, Hernández JL et al (2017) Insulin resistance in systemic lupus erythematosus patients: contributing factors and relationship with subclinical atherosclerosis. Clin Exp Rheumatol 35:885–892Google Scholar
  28. 28.
    Gheita TA, Raafat HA, Sayed S, El-Fishawy H, Nasrallah MM, Abdel-Rasheed E (2013) Metabolic syndrome and insulin resistance comorbidity in systemic lupus erythematosus. Effect on carotid intima-media thickness. Z Rheumatol 72: 172–177Google Scholar
  29. 29.
    Escárcega RO, García-Carrasco M, Fuentes-Alexandro S, Jara LJ, Rojas-Rodriguez J, Escobar-Linares LE, Cervera R (2006) Insulin resistance, chronic inflammatory state and the link with systemic lupus erythematosus-related coronary disease. Autoimmun Rev 6:48–53CrossRefGoogle Scholar
  30. 30.
    Ormseth MJ, Swift LL, Fazio S, Linton MF, Raggi P, Solus JF, Oeser A, Bian A, Gebretsadik T, Shintani A, Stein CM (2013) Free fatty acids are associated with metabolic syndrome and insulin resistance but not inflammation in systemic lupus erythematosus. Lupus 22:26–33CrossRefGoogle Scholar
  31. 31.
    Castillo-Hernandez J, Maldonado-Cervantes MI, Reyes JP, Patiño-Marin N, Maldonado-Cervantes E, Solorzano-Rodriguez C et al (2017) Obesity is the main determinant of insulin resistance more than the circulating pro-inflammatory cytokines levels in rheumatoid arthritis patients. Rev Bras Reumatol 57:320–329CrossRefGoogle Scholar
  32. 32.
    Metsios GS, Koutedakis Y, Veldhuijzen van Zanten JJ, Stavropoulos-Kalinoglou A, Vitalis P, Duda JL, Ntoumanis N, Rouse PC, Kitas GD (2015) Cardiorespiratory fitness levels and their association with cardiovascular profile in patients with rheumatoid arthritis: a cross-sectional study. Rheumatology (Oxford) 54:2215–2220Google Scholar
  33. 33.
    Cancino RJ, Soto SJ, Zbinden FH, Moreno GM, Leyton DB, González RL (2018) Cardiorespiratory fitness and fat oxidation during exercise as protective factors for insulin resistance in sedentary women with overweight or obesity. Nutr Hosp 35:312–317Google Scholar
  34. 34.
    Yates T, Henson J, Edwardson C, Dunstan D, Bodicoat DH, Khunti K, Davies MJ (2015) Objectively measured sedentary time and associations with insulin sensitivity: importance of reallocating sedentary time to physical activity. Prev Med 76:79–83CrossRefGoogle Scholar
  35. 35.
    Jelleyman C, Edwardson CL, Henson J, Gray LJ, Rowlands AV, Khunti K et al (2017) Associations of physical activity intensities with markers of insulin sensitivity. Med Sci Sports Exerc 49:2451–2458CrossRefGoogle Scholar
  36. 36.
    Duvivier BM, Schaper NC, Hesselink MK, van Kan L, Stienen N, Winkens B et al (2017) Breaking sitting with light activities vs structured exercise: a randomised crossover study demonstrating benefits for glycemic control and insulin sensitivity in type 2 diabetes. Diabetologia 60:490–498CrossRefGoogle Scholar
  37. 37.
    Oreska S, Spiritovic M, Cesak P, Marecek O, Storkanova H, Smucrova H et al (2018) Changes of body composition in myositis patients are associated with disease duration, inflammatory status, skeletal muscle involvement and physical activity. Ann Rheum Dis 77:1532Google Scholar

Copyright information

© International League of Associations for Rheumatology (ILAR) 2019

Authors and Affiliations

  1. 1.Division of Rheumatology, Hospital das Clinicas HCFMUSP, Faculdade de MedicinaUniversidade de Sao PauloSao PauloBrazil

Personalised recommendations